Show simple item record

dc.contributor.authorNewmeyer, Matthew Nicholas
dc.date.accessioned2017-06-20T12:03:57Z
dc.date.available2018-01-10T19:37:36Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/10713/6730
dc.descriptionUniversity of Maryland, Baltimore. Toxicology. Ph.D. 2017en_US
dc.description.abstractA positive drug test may result in suspension of one's driving license, loss of employment, or removal of children from the home, making it imperative that multiple factors be considered when interpreting results. Controlled research is critical for providing the data to improve result interpretation. Two drug administration studies were conducted to address drug test interpretation of opiates, amphetamines and cannabis results. In the first, participants consumed two raw, uncooked poppy seed doses (15.7 mg morphine, 3.1 mg codeine per dose), and administered seven doses of intranasal l-methamphetamine (Vicks® VapoInhaler™) per manufacturer's recommendations. Positive OF morphine tests >2.5 h or positive OF codeine tests with a 15 µg/L confirmation cutoff suggest an alternate route of opiate exposure other than from poppy seeds. Prevalence of positive OF l-methamphetamine tests was ≤7.5% and last detection times were >32 h after the first dose with a 25 µg/L screening cutoff. Screening OF with a selective d-methamphetamine assay prevented positive test results. In the second, frequent and occasional cannabis smokers were administered placebo, smoked, vaporized, and oral (6.9% Δ9-tetrahydrocannabinol [THC], ~50.6 mg) cannabis. Cannabinol (CBN) and cannabigerol (CBG) were the best blood markers for identifying recent cannabis intake, but not after oral dosing. OF Δ9-tetrahydrocannabivarin (THCV) identified use within 10 h after all administrations, useful for driving under the influence of drugs (DUID), while OF CBG may identify use within 26 h, useful for daily drug treatment compliance programs monitoring relapse. Blood 11-nor-9-carboxy-THCV (THCVCOOH) or OF THCV or CBG also discriminated medicinal synthetic THC from intake of cannabis plant products. OF THC on-site screening devices demonstrated best performance with a 5 µg/L cutoff, but there were more true positive results with a 2 µg/L cutoff; an OF THC ≥2 µg/L confirmation cutoff is suitable for drug treatment programs to detect intake within 26-32 h. Oral cannabis intake significantly increased performance impairment in occasional smokers only. Partial tolerance to cannabis' subjective effects were observed in frequent smokers after all doses. Additionally, vaporization exposed users to significantly less carbon monoxide than smoking. These data improve result interpretation and guide development of evidence-based drug policies and legislation.en_US
dc.language.isoen_USen_US
dc.subjectediblesen_US
dc.subjectevidence-based drug policyen_US
dc.subjectintranasal l-methamphetamineen_US
dc.subjectpharmacokinetics and pharmacodynamicsen_US
dc.subjectpoppy seedsen_US
dc.subject.lcshDrug testingen_US
dc.subject.meshCannabisen_US
dc.titleImproving Interpretation of Drug Exposure: Implications for Evidence-Based Drug Policyen_US
dc.typedissertationen_US
dc.contributor.advisorHuestis, Marilyn
dc.description.urinameFull Texten_US
dc.contributor.orcid0000-0002-0653-1553
refterms.dateFOA2019-02-19T18:16:37Z


Files in this item

Thumbnail
Name:
Newmeyer_umaryland_0373D_10810.pdf
Size:
6.084Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record